Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146241037> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2146241037 endingPage "7" @default.
- W2146241037 startingPage "50" @default.
- W2146241037 abstract "The LD50 of GB (sarin) given intravenously was increased more than 100-fold when rabbits were treated intravenously with atropine and 10 mg/kg of a 1:1 mixture of the monoquaternary oxime, 2-PAMCl, and a bisquaternary oxime, TMB4Cl 2 . A similar dose of TMB4 alone also antagonized this high dose of GB, but failed to save all animals at lower doses of GB. Atropine alone or the mixed oximes alone provided only minimal therapeutic effects against GB. In dogs under similar conditions, either a single oxime, 2-PAMCl, or the mixed oximes, 2-PAMCl + TMB4Cl 2 , 1:1, with atropine, saved all dogs given 70 times the LD50 of GB, but only the mixed oximes were highly effective against 70 times the LD50 of GA (tabun). When similar doses of oximes with atropine were given to rabbits prophylactically, by mouth or intramuscularly, 30 minutes before subcutaneous GB, survival occurred only after much smaller GB doses than those wherein oximeatropine therapy was given soon after GB. Tolerance for GB in cats was not a function of time for recovery of muscle function. In rabbits and mice, the bisquaternary oximes were more acutely toxic by the intravenous route than the monoquaternary type. A 1:1 mixture of the two was intermediate in toxicity. Of the oximes studied, the 1:1 mixture of the chloride salts of the mono- and bisquaternary types was most suitable for therapeutic purposes, because of its effectiveness against GB and GA, smaller acute toxicity, and greater solubility and stability of the salt form." @default.
- W2146241037 created "2016-06-24" @default.
- W2146241037 creator A5012528301 @default.
- W2146241037 creator A5032303443 @default.
- W2146241037 creator A5035870863 @default.
- W2146241037 date "1961-04-01" @default.
- W2146241037 modified "2023-09-23" @default.
- W2146241037 title "Efficacy and limitations of oxime-atropine treatment of organophosphorus anticholinesterase poisoning." @default.
- W2146241037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13730087" @default.
- W2146241037 hasPublicationYear "1961" @default.
- W2146241037 type Work @default.
- W2146241037 sameAs 2146241037 @default.
- W2146241037 citedByCount "13" @default.
- W2146241037 countsByYear W21462410372013 @default.
- W2146241037 countsByYear W21462410372016 @default.
- W2146241037 countsByYear W21462410372022 @default.
- W2146241037 crossrefType "journal-article" @default.
- W2146241037 hasAuthorship W2146241037A5012528301 @default.
- W2146241037 hasAuthorship W2146241037A5032303443 @default.
- W2146241037 hasAuthorship W2146241037A5035870863 @default.
- W2146241037 hasConcept C116263406 @default.
- W2146241037 hasConcept C155647269 @default.
- W2146241037 hasConcept C167552308 @default.
- W2146241037 hasConcept C178790620 @default.
- W2146241037 hasConcept C181199279 @default.
- W2146241037 hasConcept C185592680 @default.
- W2146241037 hasConcept C2775859210 @default.
- W2146241037 hasConcept C2776130705 @default.
- W2146241037 hasConcept C2778706303 @default.
- W2146241037 hasConcept C2778816929 @default.
- W2146241037 hasConcept C2779648554 @default.
- W2146241037 hasConcept C29730261 @default.
- W2146241037 hasConcept C3017650105 @default.
- W2146241037 hasConcept C33070731 @default.
- W2146241037 hasConcept C42219234 @default.
- W2146241037 hasConcept C55493867 @default.
- W2146241037 hasConcept C71924100 @default.
- W2146241037 hasConcept C86803240 @default.
- W2146241037 hasConcept C98274493 @default.
- W2146241037 hasConceptScore W2146241037C116263406 @default.
- W2146241037 hasConceptScore W2146241037C155647269 @default.
- W2146241037 hasConceptScore W2146241037C167552308 @default.
- W2146241037 hasConceptScore W2146241037C178790620 @default.
- W2146241037 hasConceptScore W2146241037C181199279 @default.
- W2146241037 hasConceptScore W2146241037C185592680 @default.
- W2146241037 hasConceptScore W2146241037C2775859210 @default.
- W2146241037 hasConceptScore W2146241037C2776130705 @default.
- W2146241037 hasConceptScore W2146241037C2778706303 @default.
- W2146241037 hasConceptScore W2146241037C2778816929 @default.
- W2146241037 hasConceptScore W2146241037C2779648554 @default.
- W2146241037 hasConceptScore W2146241037C29730261 @default.
- W2146241037 hasConceptScore W2146241037C3017650105 @default.
- W2146241037 hasConceptScore W2146241037C33070731 @default.
- W2146241037 hasConceptScore W2146241037C42219234 @default.
- W2146241037 hasConceptScore W2146241037C55493867 @default.
- W2146241037 hasConceptScore W2146241037C71924100 @default.
- W2146241037 hasConceptScore W2146241037C86803240 @default.
- W2146241037 hasConceptScore W2146241037C98274493 @default.
- W2146241037 hasLocation W21462410371 @default.
- W2146241037 hasOpenAccess W2146241037 @default.
- W2146241037 hasPrimaryLocation W21462410371 @default.
- W2146241037 hasRelatedWork W1993211322 @default.
- W2146241037 hasRelatedWork W2002381241 @default.
- W2146241037 hasRelatedWork W2034480432 @default.
- W2146241037 hasRelatedWork W2079756738 @default.
- W2146241037 hasRelatedWork W2085858719 @default.
- W2146241037 hasRelatedWork W2146241037 @default.
- W2146241037 hasRelatedWork W2336712643 @default.
- W2146241037 hasRelatedWork W2413402566 @default.
- W2146241037 hasRelatedWork W2885712872 @default.
- W2146241037 hasRelatedWork W4224212594 @default.
- W2146241037 hasVolume "132" @default.
- W2146241037 isParatext "false" @default.
- W2146241037 isRetracted "false" @default.
- W2146241037 magId "2146241037" @default.
- W2146241037 workType "article" @default.